Analystreport

Ultragenyx Pharmaceutical (RARE) had its price target lowered by Barclays PLC from $44.00 to $43.00. They now have an "overweight" rating on the stock.

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations